|
|
Volumn 5, Issue 1, 2006, Pages 7-9
|
|
Pharma's year of trouble and strife
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA4 INTEGRIN;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
CELECOXIB;
COMPLEMENTARY DNA;
CYCLOOXYGENASE 2 INHIBITOR;
DNA POLYMERASE;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
FORMOTEROL FUMARATE;
HYDRALAZINE PLUS ISOSORBIDE DINITRATE;
IBUPROFEN;
MESSENGER RNA;
NAPROXEN;
NATALIZUMAB;
NESIRITIDE;
OSELTAMIVIR;
PARECOXIB;
PLACEBO;
RIBONUCLEASE H;
ROFECOXIB;
SALMETEROL XINAFOATE;
SIMVASTATIN;
VALDECOXIB;
DRUG;
NEW DRUG;
ARTHRITIS;
ARTICLE;
ASTHMA;
AVIAN INFLUENZA;
CLINICAL TRIAL;
DATA BASE;
DEMYELINATING DISEASE;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DOG;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG RESPONSE;
DRUG SAFETY;
DRUG WITHDRAWAL;
ENZYME ACTIVITY;
FOOD AND DRUG ADMINISTRATION;
GENE MAPPING;
HEALTH CARE POLICY;
HEART ARRHYTHMIA;
HEART FAILURE;
HUMAN;
INTERNET;
KIDNEY INJURY;
MARKER GENE;
MOLECULAR CLONING;
MORTALITY;
MULTIPLE SCLEROSIS;
NONHUMAN;
PATENT;
PHARMACOGENOMICS;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
STEM CELL TRANSPLANTATION;
STEVENS JOHNSON SYNDROME;
TREATMENT FAILURE;
UNITED STATES;
SAFETY;
STANDARD;
CLINICAL TRIALS;
CONSUMER PRODUCT SAFETY;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUGS, INVESTIGATIONAL;
PHARMACEUTICAL PREPARATIONS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 33644862348
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd1944 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|